Navigation Links
Ajinomoto Food Ingredients LLC Expands Capabilities
Date:8/26/2009

CHICAGO, Aug. 26 /PRNewswire/ -- Ajinomoto Food Ingredients LLC has expanded its North America headquarters in Chicago by adding food product development capabilities. The Application Center North America (ACNA) was dedicated on August 3, 2009.

The ACNA mission is to develop and expand food and beverage applications for Ajinomoto technologies. Four food technology applications will be the initial focus of the Center: salt reduction, sugar replacement, textural improvement, and incorporation of ingredients to improve health.

"Ajinomoto is excited at the prospect of pursuing the best ways to bring the value of our cutting edge technologies to customers in North America," said Brendan Naulty, President, Ajinomoto Food Ingredients. "Health professionals increasingly stress the consumer health benefits of salt and sugar reductions. We are in the perfect position to provide tools to meet these goals without compromising food taste and enjoyment," he added.

Ajinomoto Food Ingredients LLC opened its Chicago office in 2004, a move from its prior location in Paramus, New Jersey. The ACNA includes a new analytical laboratory with state-of-the-art HPLC. Leading the Center is Jiro Sakamoto, Executive Director, Business Development & Application Innovation, who has been with Ajinomoto for 22 years. Sakamoto will be supported by four food development scientists who bring a combined 100 years of food product development knowledge.

"This is a huge step forward both for Ajinomoto and our customers, reflecting our commitment to leadership in the North America food ingredient market," Naulty said.

Ajinomoto's mission is to contribute significant advances to food and health and ultimately to a better life for all.


'/>"/>
SOURCE Ajinomoto Food Ingredients LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO., INC.
2. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
3. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
4. Quantum dots and nanomaterials: Ingredients for better lighting and more reliable power
5. Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
6. The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
9. BioLife Solutions Expands Scientific Advisory Board
10. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
11. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):